GEO Publications
Handout
NAR 2024 (latest)
NAR 2002 (original)
All publications
FAQ
MIAME
Email GEO
NCBI
>
GEO
>
Accession Display
Not logged in |
Login
GEO help:
Mouse over screen elements for information.
Scope:
Self
Platform
Samples
Series
Family
Format:
HTML
SOFT
MINiML
Amount:
Brief
Quick
GEO accession:
Sample GSM39457
Query DataSets for GSM39457
Status
Public on Apr 01, 2005
Title
ms186-7
Sample type
RNA
Source name
Staged C. elegans embryos
Organism
Caenorhabditis elegans
Extracted molecule
total RNA
Description
Mutant genotype mex-3(zu155); skn-1(RNAi) 186 minutes after the 4-cell embryonic stage at 22 degrees C
Sample_genotype: ms
Sample_time: 186
Submission date
Jan 24, 2005
Last update date
May 27, 2005
Contact name
Andrew Hill
E-mail(s)
andrew.hill@pfizer.com
Phone
617-674-6341
Organization name
Pfizer
Department
Research Business Technology
Street address
300 Technology Square
City
Cambridge
State/province
MA
ZIP/Postal code
02139
Country
USA
Platform ID
GPL200
Series (1)
GSE2180
C. elegans embryonic timecourse in wt and mutant embryos
Data table header descriptions
ID_REF
Affymetrix Qualifier
VALUE
RMA calulated using Bioconductor Affy package (http://www.bioconductor.org)
Data table
ID_REF
VALUE
171720_x_at
5.25241005318865
171721_x_at
6.33642653396931
171722_x_at
6.71460424803686
171723_x_at
3.81370790177965
171724_x_at
5.08654723484251
171725_x_at
4.90374409189942
171726_x_at
4.74231242646335
171727_x_at
3.06999781225676
171728_x_at
3.02124359897081
171729_x_at
7.4067192806967
171730_x_at
2.76419128745067
171731_x_at
7.51468512604174
171732_x_at
6.20089309044422
171733_x_at
7.98809304459344
171734_x_at
9.22081534027275
171735_x_at
4.83976297494516
171736_x_at
7.96601897112608
171737_x_at
8.51257288679057
171738_x_at
6.4108158436693
171739_x_at
3.33597749303045
Total number of rows:
22625
Table truncated, full table size
608 Kbytes
.
Supplementary file
Size
Download
File type/resource
GSM39457.CEL.gz
2.8 Mb
(ftp)
(http)
CEL
GSM39457.EXP.gz
337 b
(ftp)
(http)
EXP
|
NLM
|
NIH
|
GEO Help
|
Disclaimer
|
Accessibility
|
